100 Participants Needed

Spinal Cord Stimulation for Pain

Recruiting at 9 trial locations
SR
CR
Overseen ByChristopher Reis, DO
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: MedtronicNeuro
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

To characterize the effects of stimulation parameters on pain relief and other cohort specific outcomes.

Are You a Good Fit for This Trial?

This trial is for adults over 22 with limb or back pain, who have had a Medtronic rechargeable neurostimulation system implanted for at least one month. Participants must understand English, be able to follow the study's procedures and document their experience. Pregnant women or those not using birth control are excluded.

Inclusion Criteria

You are willing and able to comply with all study procedures, including diary completion, and visits.
Willing and able to provide signed and dated informed consent
Capable of comprehending and consenting in English
See 3 more

Exclusion Criteria

You have a non-rechargeable neurostimulator, and it's impossible to predict how long the battery will last.
You have a device implanted in your body that is being used for a purpose that hasn't been approved by the authorities.
You are already participating or planning to participate in another study that could affect the results of this study.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive spinal cord stimulation with various programming settings to assess pain relief

Up to 8 months

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Spinal Cord Stimulation
Trial Overview The SCS Research Study is examining how different spinal cord stimulation settings affect pain relief in patients with chronic limb and back pain. It focuses on personalizing treatment by assessing outcomes specific to each participant.
How Is the Trial Designed?
9Treatment groups
Experimental Treatment
Group I: Cohort 9: Diabetic Peripheral Neuropathy (DPN) FlowExperimental Treatment1 Intervention
Group II: Cohort 8: Differential Targeted Multiplexed (DTM) for Neuro Sense (NS)Experimental Treatment1 Intervention
Group III: Cohort 7: Super CycleExperimental Treatment1 Intervention
Group IV: Cohort 6: Differential Targeted Multiplexed-Low Energy Spinal Cord Stimulation (DTM-LE SCS)Experimental Treatment1 Intervention
Group V: Cohort 5: Low Energy Cycling 2Experimental Treatment1 Intervention
Group VI: Cohort 4: Low Energy Cycling 1Experimental Treatment1 Intervention
Group VII: Cohort 3: Cycling EvolveExperimental Treatment1 Intervention
Group VIII: Cohort 2: InterleavingExperimental Treatment1 Intervention
Group IX: Cohort 1: Low Energy - ContinuousExperimental Treatment1 Intervention

Spinal Cord Stimulation is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as Spinal Cord Stimulation for:
🇪🇺
Approved in European Union as Spinal Cord Stimulation for:
🇨🇦
Approved in Canada as Spinal Cord Stimulation for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

MedtronicNeuro

Lead Sponsor

Trials
72
Recruited
20,900+

Geoff Martha

MedtronicNeuro

Chief Executive Officer since 2020

Finance degree from Penn State University

Dr. Eric Peterson

MedtronicNeuro

Chief Medical Officer since 2020

MD from University of Miami

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security